Loading…
LeMaitre Vascular, Inc. is projected to rise to $113.17 by 2027, a +11% move from its current price of $102.19. LMAT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $100.32 | $102.18 | $104.06 | -0.01% |
| Aug 2 | $99.55 | $102.16 | $104.83 | -0.03% |
| Aug 3 | $98.96 | $102.15 | $105.43 | -0.04% |
| Aug 4 | $98.47 | $102.13 | $105.93 | -0.06% |
| Aug 5 | $98.03 | $102.12 | $106.37 | -0.07% |
| Aug 6 | $97.63 | $102.10 | $106.78 | -0.09% |
| Aug 7 | $97.27 | $102.09 | $107.14 | -0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $97.27 | $102.09 | $107.14 | -0.10% |
| Week 2 | $95.24 | $101.98 | $109.20 | -0.20% |
| Week 3 | $93.69 | $101.88 | $110.78 | -0.31% |
| Week 4 | $92.39 | $101.77 | $112.11 | -0.41% |
| Week 5 | $91.25 | $101.67 | $113.28 | -0.51% |
| Week 6 | $90.22 | $101.57 | $114.34 | -0.61% |
| Week 7 | $89.28 | $101.46 | $115.31 | -0.71% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LeMaitre Vascular, Inc. is a healthcare company that develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services.
It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001.
LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
LeMaitre Vascular, Inc. (LMAT) is a healthcare company that trades with a current price of $102.30 and a market cap of $2.34B, ranking 1852 by market capitalization. The stock sits in the Healthcare category and is analyzed with a set of price targets and a long‑term forecast that shows a bullish growth trajectory through 2050.
At present, the market reflects a neutral near‑term stance, but the longer‑term outlook points to substantial upside based on the provided forecast figures.
A major floor 20.0% below — a decisive break under it would weaken the trend.
The nearest floor, 13.3% below — buyers have tended to step in here.
The nearest ceiling, 3.4% above — a clean break opens room to run.
A major ceiling 14.9% above — clearing it would confirm fresh momentum.
Key LMAT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LMAT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $100.52 | Buy | $101.39 | Buy |
| MA 10 | $100.28 | Buy | $100.73 | Buy |
| MA 20 | $101.15 | Buy | $100.00 | Buy |
| MA 50 | $97.25 | Buy | $99.56 | Buy |
| MA 100 | $103.32 | Sell | $99.32 | Buy |
| MA 200 | $95.53 | Buy | $96.94 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.32 | Neutral |
| Stoch RSI (14) | 80.08 | Sell |
| CCI (20) | 34.87 | Neutral |
| Williams %R (14) | -17.29 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | 4.42 | Buy |
| Bollinger %B (20,2) | 0.61 | Neutral |
| Stochastic %K (14) | 82.71 | Sell |
| TRIX (15) | 0.14 | Buy |
| Awesome (5,34) | 2.52 | Buy |
| Ultimate (7,14,28) | 53.93 | Neutral |
| Momentum (10) | -0.84 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 102.87 | Sell |
| ADX (14) | 13.55 | Neutral |
| ATR (14) | 1.83 | Info |
Technically, the 30‑day picture is NEUTRAL. The RSI14 sits at 50, with a SMA50 of $97.09 and a SMA200 of $95.25, indicating a balanced short‑term trend. Near‑term support is listed at $88.61 and resistance at $105.70, framing a chart that leans neither overtly bullish nor bearish.
Over the last 30 days, the price has traded within a range of $91.27 to $114.66, underscoring a contained near‑term volatility profile with an annualized volatility of 30.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $80.17 | $102.19 | $129.82 | 0% | Neutral | |
| $92.79 | $113.17 | $144.23 | +11% | Neutral | |
| $102.87 | $127.85 | $167.41 | +25% | Bullish | |
| $105.17 | $132.74 | $177.56 | +30% | Bullish | |
| $118.78 | $151.96 | $206.96 | +49% | Bullish | |
| $149.61 | $193.75 | $268.07 | +90% | Bullish | |
| $155.38 | $203.51 | $285.60 | +99% | Bullish | |
| $162.70 | $215.35 | $306.14 | +111% | Bullish | |
| $176.94 | $236.52 | $340.28 | +131% | Bullish | |
| $176.23 | $237.82 | $345.96 | +133% | Bullish | |
| $273.54 | $385.03 | $587.06 | +277% | Bullish | |
| $457.04 | $690.00 | $1,127.86 | +575% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $80.17 | $102.19 | $119.03 | +0.00% |
| August 2026 | $87.39 | $101.90 | $121.08 | -0.29% |
| September 2026 | $85.99 | $100.84 | $120.96 | -1.03% |
| October 2026 | $87.84 | $103.49 | $125.05 | +2.62% |
| November 2026 | $89.86 | $106.26 | $129.18 | +2.69% |
| December 2026 | $89.51 | $106.21 | $129.82 | -0.05% |
Click any year to see its month-by-month LMAT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, LMAT is projected to trade between $80.17 and $129.82, averaging $102.19 — a potential gain of 0% from today's $102.19. A consolidation phase looks the most probable path here.
LeMaitre Vascular, Inc.'s 2027 outlook centres on $113.17, within a $92.79 to $144.23 range. That is up +11% on the projected 2026 average. That marks a +11% change versus current levels. Price action looks broadly range-bound.
By 2028, LMAT could reach as high as $167.41, with a base case around $127.85 and support toward $102.87 — roughly +25% from $102.19. Buyers look set to stay in control over this stretch.
Expect LMAT to range from $105.17 to $177.56 through 2029. The $132.74 average target implies a +30% move from current prices. That is up +4% on the projected 2028 average. Momentum favours further upside here.
The LMAT price prediction for 2030 points to an average of $151.96 (low $118.78, high $206.96) — a potential gain of +49% on today's $102.19. Buyers look set to stay in control over this stretch.
In 2031, LMAT is projected to trade between $149.61 and $268.07, averaging $193.75 — a potential gain of +90% from today's $102.19. That is up +28% on the projected 2030 average. Momentum favours further upside here.
LeMaitre Vascular, Inc.'s 2032 outlook centres on $203.51, within a $155.38 to $285.60 range. That is up +5% on the projected 2031 average. That marks a +99% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, LMAT could reach as high as $306.14, with a base case around $215.35 and support toward $162.70 — roughly +111% from $102.19. Momentum favours further upside here.
Expect LMAT to range from $176.94 to $340.28 through 2034. The $236.52 average target implies a +131% move from current prices. That is up +10% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The LMAT price prediction for 2035 points to an average of $237.82 (low $176.23, high $345.96) — a potential gain of +133% on today's $102.19. Momentum favours further upside here.
In 2040, LMAT is projected to trade between $273.54 and $587.06, averaging $385.03 — a potential gain of +277% from today's $102.19. That is up +62% on the projected 2035 average. Buyers look set to stay in control over this stretch.
LeMaitre Vascular, Inc.'s 2050 outlook centres on $690.00, within a $457.04 to $1,127.86 range. That is up +79% on the projected 2040 average. That marks a +575% change versus current levels. Momentum favours further upside here.
Investing $1,000 in LMAT today (≈ 9.785693 LMAT) could be worth
$6,752.17
+$5,752.17 (+575%) by 2050 · US Dollar
Based on the average projected LMAT price of $690 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LMATwould be worth at today's price.
$1,000 invested in LMAT on Jul 30, 2025 (≈ 12.199585 LMAT) would be worth
$1,246.68
+$246.68 (+24.7%) today · 1.25× · US Dollar
Based on a LMAT entry price of $81.97 vs. today's $102.19.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $97.49 | $1,048.21 | +4.8% |
| 1 month ago | $95.96 | $1,064.92 | +6.5% |
| 3 months ago | $112.04 | $912.08 | -8.8% |
| 6 months ago | $84.97 | $1,202.66 | +20.3% |
| 1 year ago | $81.97 | $1,246.68 | +24.7% |
| All time (5.0y) ago | $54.71 | $1,867.85 | +86.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LMAT forecast.
Our base-case forecast reaches $200.00 around 2032.
Implied market cap at $200.00: $4.57B
The multi‑year forecast lays out a clear, bullish trajectory from 2026 onward. In 2026 the average price is $102.30 with a min of $80.17 and a max of $129.29. By 2027, the average advances to $111.54 and the range to $91.44–$142.17, with an ROI of 9.
The ascent continues in 2028 to an average of $124.19 (min $99.92, max $162.64) and an ROI of 21.4, with sentiment labeled BULLISH. In 2029 the average price is $127.32 (min $100.87, max $170.33) and ROI 24.5, still BULLISH. By 2030 the average reaches $144.14 (min $112.66, max $196.33) with ROI 40.9 and a BULLISH stance.
The forecast then shows continued strength through 2031 ($182.26 avg, $78.2 ROI), 2032 ($190.45 avg, $86.2 ROI), 2033 ($200.91 avg, $96.4 ROI), 2034 ($219.29 avg, $114.4 ROI), and 2035 ($218.83 avg, $113.9 ROI), all BULLISH. Looking further out, 2040 projects an average of $347.55 with a min of $246.90 and a max of $529.93, ROI 239.7, still bullish. By 2050 the average is $609.10 (min $403.44, max $995.65) with ROI 495.4, and a strongly bullish sentiment.
These figures depict a long‑term growth path, though they are estimates and not guarantees.
Tap a question to reveal the answer.
Average price $144.14; min $112.66; max $196.33; ROI 40.9; sentiment BULLISH.
The long‑term forecast shows a bullish trajectory with rising average prices and increasing ROI through 2050 (e.g., avg $609.10 in 2050 and ROI 495.4). Near term, 2026–2027 are NEUTRAL, with bullish momentum beginning in 2028 and continuing thereafter.
Yes. The 2033 forecast lists an average price of $200.91, indicating a crossing of $200 in the outlook.
Current price $102.30; market cap $2.34B.
Low $91.27; High $114.66.
LeMaitre Vascular, Inc. Community Discussion
0Share your LeMaitre Vascular, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.